BioCentury
ARTICLE | Company News

GSK confirms management overhaul

January 10, 2018 1:06 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) has replaced about 40% of its top management team since CEO Emma Walmsley took the helm in April 2017, the pharma confirmed to BioCentury Tuesday.

GSK spokesperson Sarah Spencer told BioCentury the changes include several new hires, including former Novartis AG (NYSE:NVS; SIX:NOVN) executives Tobias Hestler as consumer CFO and Christine Roth as head of oncology. Chief Procurement Officer Lisa Martin joined GSK's team from Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA), Marc Speichert came on as consumer chief digital officer from Google Inc. and Tony Wood joined GSK's R&D team from Pfizer Inc. (NYSE:PFE)...